» Articles » PMID: 8566942

Familial Non-syndromic Conotruncal Defects Are Not Associated with a 22q11 Microdeletion

Overview
Journal Hum Genet
Specialty Genetics
Date 1996 Feb 1
PMID 8566942
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular studies have shown microdeletions in region q11 of chromosome 22 in nearly all patients with DiGeorge, velocardiofacial and conotruncal anomaly face syndromes (DGS, VCFS and CTAFS, respectively) and in a high percentage of non-syndromic familial cases of conotruncal defects (CTD). CTD account for roughly a fourth to a third of all non-syndromic congenital heart defects (CHD), thus, 22q11 could harbor a major genetic factor of CHD. We searched for a 22q11 microdeletion in familial cases of non-syndromic CTD. Thirty-six cases of various isolated CTD, that is without history of hypocalcemia, immune deficiency, absent thymus, and dysmorphic appearance, were selected. With 48F8, a cosmid probe localized in the smallest deleted region of the DiGeorge critical region (DGCR), we found no deletions by fluorescence in situ hybridization in these 36 affected individuals of 16 families with recurrent CTD. Moreover, D22S264, a microsatellite localized at the distal part of the largest deleted region, was used to genotype the patients. Thirty-two patients out of 37 were heterozygous and hence not deleted at this locus, whereas 5 were uninformative. In conclusion, there are no large deletions in familial cases of various CTD, whether these defects are identical or not within a family. This result does not rule out other minor anomalies in this chromosomal region.

Citing Articles

The association of elevated maternal genetic risk scores for hypertension, type 2 diabetes and obesity and having a child with a congenital heart defect.

Kaplinski M, Taylor D, Mitchell L, Hammond D, Goldmuntz E, Agopian A PLoS One. 2019; 14(5):e0216477.

PMID: 31141530 PMC: 6541344. DOI: 10.1371/journal.pone.0216477.


Genetic variation in folate metabolism is associated with the risk of conotruncal heart defects in a Chinese population.

Wang X, Wei H, Tian Y, Wu Y, Luo L BMC Pediatr. 2018; 18(1):287.

PMID: 30165839 PMC: 6117882. DOI: 10.1186/s12887-018-1266-9.


Quantitative proteomic analysis of serum from pregnant women carrying a fetus with conotruncal heart defect using isobaric tags for relative and absolute quantitation (iTRAQ) labeling.

Zhang Y, Kang Y, Zhou Q, Zhou J, Wang H, Jin H PLoS One. 2014; 9(11):e111645.

PMID: 25393621 PMC: 4230941. DOI: 10.1371/journal.pone.0111645.


Clinical manifestations of Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome).

Digilio M, Marino B, Capolino R, Dallapiccola B Images Paediatr Cardiol. 2012; 7(2):23-34.

PMID: 22368650 PMC: 3232571.


Investigating 22q11.2 deletion and other chromosomal aberrations in fetuses with heart defects detected by prenatal echocardiography.

Bellucco F, Belangero S, Farah L, Machado M, Cruz A, Lopes L Pediatr Cardiol. 2010; 31(8):1146-50.

PMID: 20848279 DOI: 10.1007/s00246-010-9763-0.


References
1.
Pierpont M, Gobel J, MOLLER J, Edwards J . Cardiac malformations in relatives of children with truncus arteriosus or interruption of the aortic arch. Am J Cardiol. 1988; 61(6):423-7. DOI: 10.1016/0002-9149(88)90298-6. View

2.
Shprintzen R, Goldberg R, Lewin M, Sidoti E, Berkman M, Argamaso R . A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J. 1978; 15(1):56-62. View

3.
Seaver L, Pierpont J, Erickson R, Donnerstein R, Cassidy S . Pulmonary atresia associated with maternal 22q11.2 deletion: possible parent of origin effect in the conotruncal anomaly face syndrome. J Med Genet. 1994; 31(11):830-4. PMC: 1016653. DOI: 10.1136/jmg.31.11.830. View

4.
Wilson D, Goodship J, Burn J, Cross I, Scambler P . Deletions within chromosome 22q11 in familial congenital heart disease. Lancet. 1992; 340(8819):573-5. DOI: 10.1016/0140-6736(92)92107-q. View

5.
JOHNSON G, Nogueira Araujo G . A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods. 1981; 43(3):349-50. DOI: 10.1016/0022-1759(81)90183-6. View